PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Johns Hopkins researchers show how a modified pacemaker strengthens failing hearts

Findings advance opportunities for a 'pacemaker in a bottle'

2013-12-02
(Press-News.org) Contact information: Ellen Beth Levitt
eblevitt@jhmi.edu
410-955-5307
Johns Hopkins Medicine
Johns Hopkins researchers show how a modified pacemaker strengthens failing hearts Findings advance opportunities for a 'pacemaker in a bottle' Johns Hopkins heart researchers are unraveling the mystery of how a modified pacemaker used to treat many patients with heart failure, known as cardiac resynchronization therapy (CRT), is able to strengthen the heart muscle while making it beat in a coordinated fashion. In a new study conducted on animal heart cells described in the Journal of Clinical Investigation, the scientists show that CRT changes these cells so they can contract more forcefully. The researchers also identified an enzyme that mimics this effect of CRT without use of the device.

"These discoveries potentially give us new pathways to benefit more heart failure patients — not only those whose hearts beat out of sync, but also those who currently do not qualify for CRT therapy yet still need an effective treatment to help their heart pump stronger," says David Kass, M.D., professor of medicine and biomedical engineering at the Johns Hopkins University School of Medicine and senior author of the study. "Understanding the inner workings of CRT at the biological level may lead, in essence, to a 'pacemaker in a bottle.'"

The researchers say their ultimate goals are to develop drugs or genetic therapies that strengthen failing hearts and to design a test to identify patients who would be most likely to benefit from CRT.

Kass explains that while the typical implanted pacemaker has only one wire that stimulates the right side of the heart, the CRT pacemaker has two wires. The second wire goes to the surface of the left side of the heart to enable both sides of the heart to be stimulated together.

CRT helps people whose hearts beat out of sync — one side is activated to "beat" before the other, preventing the muscle from pumping blood evenly. This condition is known as dyssynchrony. CRT "paces" the rhythms of both sides to restore a coordinated beat.

In their experiments, the researchers used an animal model of heart failure with dyssynchrony and also examined the impact of CRT on the heart. By studying isolated muscle tissue and muscle cells, they examined the relationship between contraction and the calcium that triggers it. In the hearts that beat out of sync, force from the muscle cells and the level of calcium needed to generate contractions were very much reduced. CRT improved contraction force more than calcium, and this led to the discovery that CRT had increased the sensitivity of the muscle to calcium.

The next question was how this change had occurred. Calcium sensitivity is a property of the proteins that form the contracting "engine" of muscle, so the investigators examined how these proteins had been biochemically altered by CRT. After ruling out all the known ways this might have occurred, they turned to a newer approach, testing for changes in more than 150 proteins and discovered that CRT specifically modified 13 of them.

"Once we discovered which proteins were being altered, we were able to identify an enzyme likely responsible for these changes," noted lead author Jonathan Kirk, Ph.D., a post-doctoral fellow at the Johns Hopkins University School of Medicine. Working with heart muscle and isolated cells from the same animal models, the researchers found that the enzyme turned out to be GSK-3 beta, which was able to convert the behavior of muscle cells from a heart that was beating out of sync to what looked like heart cells that had received CRT, essentially mimicking the effect of CRT.

In further lab experiments, Kass and his colleagues found that although GSK-3 beta was inactive in muscle from a failing and dyssynchronous heart, it was reactivated by CRT. When that happened, the enzyme altered the motor proteins so that they generated greater force using the same amount of calcium-based activation.

"It had never been shown before that GSK-3 beta could modify motor proteins in the heart to make them more sensitive to calcium. It is surprising that this same type of effect can be produced by a pacemaker therapy like CRT," says Kass.

Nearly all existing medications for heart failure increase heart contraction by enhancing levels of calcium available to muscle cells, but over time, these higher levels can be toxic to the heart.

Altering the calcium sensitivity of the muscle is not the only way CRT can improve heart function. In a study published in 2011, Kass and colleagues also showed that CRT enables heart muscle to respond to hormones, such as adrenaline, which stimulates pumping ability, in a similar way to what happens during exercise.

The Kass Lab played a key role in developing CRT for use in patients in the late 1990s. The Food and Drug Administration approved CRT in 2001, and it is widely used today to improve symptoms and help people live longer.

In an unusual twist to the way therapies are usually developed, CRT was first tested in patients, but the biological mechanisms as to why it worked were not understood. The new work is running the discovery clock backwards, revealing these mechanisms and their potential to benefit many patients with heart failure.

###

In addition to Kass and Kirk, other authors on the study were: Ronald J. Holewinski, Viola Kooij, Wei Dong Gao and Jennifer Van Eyk from the Johns Hopkins University School of Medicine; Giulio Agnetti from the University of Bologna; and Richard S. Tunin, Namthip Witayavanitkul and Pieter P. de Tombe from the Stritch School of Medicine at Loyola University, Chicago.

Here is a link to the full study article: http://www.jci.org/articles/view/69253?key=fdd04e03e5fcde1d87d4

For more information about the Johns Hopkins Heart and Vascular Institute: http://www.hopkinsmedicine.org/heart_vascular_institute/

Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading academic health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's vision, "Together, we will deliver the promise of medicine," is supported by its mission to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, and more than 35 Johns Hopkins Community Physicians sites. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years in a row by U.S. News & World Report. For more information about Johns Hopkins Medicine, its research, education and clinical programs, and for the latest health, science and research news, visit http://www.hopkinsmedicine.org.

Media Contacts:
Ellen Beth Levitt, eblevitt@jhmi.edu, 410-955-5307
Helen Jones, hjones49@jhmi.edu, 410-502-9422

END



ELSE PRESS RELEASES FROM THIS DATE:

Evolution, Civil War history entwine in plant fossil with a tragic past

2013-12-02
Evolution, Civil War history entwine in plant fossil with a tragic past Union Army forced freed slaves to dig canal where 120 million-year-old fossil plant was found COLLEGE PARK, Md – A fossil leaf fragment collected decades ago on a Virginia canal bank has been identified ...

Key found to restoring 'exhausted' HIV-fighting immune cells

2013-12-02
Key found to restoring 'exhausted' HIV-fighting immune cells Protein could prove a promising new drug target Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in ...

New evidence that 'gout' strongly runs in the family

2013-12-02
New evidence that 'gout' strongly runs in the family It's historically known as 'the king of diseases and the disease of kings' and was long thought to be caused by an overindulgent lifestyle, but now scientists at The University of Nottingham have confirmed ...

Researchers analyze growth potential in African bank loans

2013-12-02
Researchers analyze growth potential in African bank loans In Africa, small women-owned business owners find it easier to obtain loans than their male counterparts. The reason for this distortion is that politicians and foreign aid organisations with their focus on bank ...

Congenital heart defects affects long-term developmental outcome

2013-12-02
Congenital heart defects affects long-term developmental outcome Approximately one percent of all newborns in Switzerland are diagnosed with a congenital heart defect, roughly half of them require open heart surgery. Most children, including those with the most severe ...

New research shows obesity is an inflammatory disease

2013-12-02
New research shows obesity is an inflammatory disease New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and ...

EASAC report warns Europe on extreme weather event increase

2013-12-02
EASAC report warns Europe on extreme weather event increase First comprehensive survey shows 60 percent rise over last 30 years of floods, droughts and storms Europe needs to plan for future probabilities of extreme weather. Heat waves, ...

Athletes and the words for actions

2013-12-02
Athletes and the words for actions A study investigates the role of the motor system in conceptualization Is it true, as some scientists believe, that to understand words like "spike" (in the volleyball sense) the brain has to "mentally" ...

IQWiG publishes new version of its General Methods

2013-12-02
IQWiG publishes new version of its General Methods Procedure for report production and section on meta-analyses updated / New sections on early benefit assessment The German Institute for Quality and Efficiency in Health Care (IQWiG) ...

Detailed image shows how genomes are copied

2013-12-02
Detailed image shows how genomes are copied For the first time, researchers at Umeå University have succeeded in showing how the DNA polymerase epsilon enzyme builds new genomes. The detailed image produced by these researchers shows how ...

LAST 30 PRESS RELEASES:

Recent advances in dynamic biomacromolecular modifications and chemical interventions: Perspective from a Chinese chemical biology consortium

CRF and the Jon DeHaan Foundation to launch TCT AI Lab at TCT 2025

Canada’s fastest academic supercomputer is now online at SFU after $80m upgrades

Architecture’s past holds the key to sustainable future

Laser correction for short-sightedness is safe and effective for older teenagers

About one in five people taking Ozempic, Wegovy or Mounjaro say food tastes saltier or sweeter than before

Taking semaglutide turns down food noise, research suggests

Type 2 diabetes may double risk of sepsis, large community-based study suggests

New quantum sensors can withstand extreme pressure

Tirzepatide more cost-effective than semaglutide in patients with knee osteoarthritis and obesity

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity

Interactive apps, AI chatbots promote playfulness, reduce privacy concerns

How NIL boosts college football’s competitive balance

Moffitt researchers develop machine learning model to predict urgent care visits for lung cancer patients

Construction secrets of honeybees: Study reveals how bees build hives in tricky spots

Wheat disease losses total $2.9 billion across the United States and Canada between 2018 and 2021

New funding fuels development of first potentially regenerative treatment for multiple sclerosis

NJIT student–faculty team wins best presentation award for ant swarm simulation

Ants defend plants from herbivores but can hinder pollination

When the wireless data runs dry

Inquiry into the history of science shows an early “inherence” bias

Picky eaters endure: Ecologists use DNA to explore diet breadth of wild herbivores

Study suggests most Americans would be healthier without daylight saving time

Increasing the level of the protein PI31 demonstrates neuroprotective effects in mice

Multi-energy X-ray curved surface imaging-with multi-layer in-situ grown scintillators

Metasurface enables compact and high-sensitivity atomic magnetometer

PFAS presence confirmed in the blood of children in Gipuzkoa

Why do people believe lies?

SwRI installs private 5G network for research, development, testing and evaluation

A new perspective in bone metabolism: Targeting the lysosome–iron–mitochondria axis for osteoclast regulation

[Press-News.org] Johns Hopkins researchers show how a modified pacemaker strengthens failing hearts
Findings advance opportunities for a 'pacemaker in a bottle'